These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, report not yet due 2020-000722-26 Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transpla... 2023-12-22 not-yet-due
Completed, report not yet due Terminated 2021-003450-22 Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard o... 2023-12-22 not-yet-due
Completed, report not yet due 2021-005105-27 Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6,... 2023-12-22 not-yet-due
Listed as ongoing, but also has a completion date 2022-000763-45 Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105) 2023-12-22 bad-data